BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29207197)

  • 1. Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration.
    Shen Y; Gao Y; Yuan H; Cao J; Jia B; Li M; Peng Y; Du X; Zhang J; Shi J
    Int J Mol Med; 2018 Feb; 41(2):1147-1155. PubMed ID: 29207197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHB2 promotes tumorigenesis
    Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
    Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
    [No Abstract]   [Full Text] [Related]  

  • 3. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA.
    Héron-Milhavet L; Mamaeva D; Rochat A; Lamb NJ; Fernandez A
    J Cell Physiol; 2008 Jan; 214(1):158-65. PubMed ID: 17565718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2.
    Zhang Y; Wang LN; Lin YN; Xing YX; Shi Y; Zhao J; Chen WW; Han B
    Asian J Androl; 2018; 20(5):511-517. PubMed ID: 29956684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis.
    Tseng JC; Huang SH; Lin CY; Wang BJ; Huang SF; Shen YY; Chuu CP
    Cell Death Dis; 2020 May; 11(5):376. PubMed ID: 32415173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
    Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
    Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo effects of short hairpin RNA targeting integrin-linked kinase in prostate cancer cells.
    Yuan Y; Xiao Y; Li Q; Liu Z; Zhang X; Qin C; Xie J; Wang X; Xu T
    Mol Med Rep; 2013 Aug; 8(2):419-24. PubMed ID: 23783575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
    Riggio M; Perrone MC; Polo ML; Rodriguez MJ; May M; Abba M; Lanari C; Novaro V
    Sci Rep; 2017 Mar; 7():44244. PubMed ID: 28287129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin ligase CHIP functions as an oncogene and activates the AKT signaling pathway in prostate cancer.
    Cheng L; Zang J; Dai HJ; Li F; Guo F
    Int J Oncol; 2018 Jul; 53(1):203-214. PubMed ID: 29693147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
    Häggblad Sahlberg S; Mortensen AC; Haglöf J; Engskog MK; Arvidsson T; Pettersson C; Glimelius B; Stenerlöw B; Nestor M
    Int J Oncol; 2017 Jan; 50(1):5-14. PubMed ID: 27878243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
    Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
    Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
    Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
    Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
    Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
    Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.
    Feng S; Zhu X; Fan B; Xie D; Li T; Zhang X
    Mol Med Rep; 2016 May; 13(5):4030-8. PubMed ID: 27035427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB2/Her-2 regulates the expression of Akt2 in prostate cancer cells.
    Le Page C; Koumakpayi IH; Péant B; Delvoye N; Saad F; Mes-Masson AM
    Prostate; 2012 May; 72(7):777-88. PubMed ID: 21932427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of proliferation, invasion, and migration of prostate cancer cells by downregulating elongation factor-1alpha expression.
    Zhu G; Yan W; He HC; Bi XC; Han ZD; Dai QS; Ye YK; Liang YX; Wang J; Zhong W
    Mol Med; 2009; 15(11-12):363-70. PubMed ID: 19707524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
    Yin H; Sheng Z; Zhang X; Du Y; Qin C; Liu H; Dun Y; Wang Q; Jin C; Zhao Y; Xu T
    Oncol Rep; 2017 Feb; 37(2):1045-1051. PubMed ID: 27922675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H
    Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
    Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
    Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.